BMC Genomics

BMC Genomics is a leading open-access, peer-reviewed journal dedicated to publishing cutting-edge research across all areas of genome-scale analysis. Published by BioMed Central, part of Springer Nature, the journal has an ISSN of 1471-2164 and an Impact Factor of 3.900 as of 2026, placing it in the JCR Quartile 2 (Q2) within the field of genetics and genomics. Its scope encompasses the full breadth of genomic science, including genome sequencing, assembly, and annotation; comparative and evolutionary genomics; functional genomics; population genetics; transcriptomics; epigenomics; and metagenomics. The journal also welcomes studies on computational genomics, statistical methods for genomic data analysis, and the application of genomics to medical, agricultural, and environmental research. BMC Genomics primarily publishes original research articles, as well as reviews, methodology articles, software descriptions, and database reports, ensuring comprehensive coverage of both fundamental and applied genomic discoveries. The target audience includes academic researchers, bioinformaticians, molecular biologists, geneticists, and clinicians who seek timely and rigorous genomic insights. A defining feature of the journal is its fully open-access model, ensuring that all published articles are freely available to readers worldwide, which maximizes visibility and impact. The journal stands as a reputable and accessible venue in the genomics community, with its Q2 ranking reflecting solid performance and broad recognition among peers. Its commitment to rapid peer review, high editorial standards, and a broad scope makes BMC Genomics a key resource for disseminating significant genomic data and discoveries, particularly for studies requiring immediate and unrestricted access.